{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:03:07Z","timestamp":1792180987752,"version":"4.4.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Instituto Carlos Chagas"},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto Oswaldo Cruz and the British Society for Antimicrobial Chemotherapy"},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["614562"],"award-info":[{"award-number":["614562"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/R008485\/1"],"award-info":[{"award-number":["BB\/R008485\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wolfson Royal Society Research"},{"DOI":"10.13039\/501100006506","name":"Brazilian Ministry of Health","doi-asserted-by":"publisher","award":["440015\/2018-9"],"award-info":[{"award-number":["440015\/2018-9"]}],"id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["405520\/2018-2"],"award-info":[{"award-number":["405520\/2018-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301304\/2017-3"],"award-info":[{"award-number":["301304\/2017-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["VPPCB-007-FIO-18"],"award-info":[{"award-number":["VPPCB-007-FIO-18"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["VPPIS-001-FIO18"],"award-info":[{"award-number":["VPPIS-001-FIO18"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia de Inova\u00e7\u00e3o em Doen\u00e7as de Popula\u00e7\u00f5es Negligenciadas"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cryptococcosis is a life-threatening fungal infection. New therapeutic approaches are necessary to combat cryptococcosis, as the currently available therapeutic protocols are expensive and generally result in deleterious side effects. Pyrifenox is an antifungal compound that affects phytopathogens by inhibiting the biosynthesis of ergosterol. In this study, we investigated the effects of pyrifenox on Cryptococcus neoformans and Cryptococcus gattii growth, capsule architecture and export of the major capsule component, glucuroxylomannan (GXM). Pyrifenox inhibited the growth of C. neoformans, but was significantly less effective against C. gattii. The resistance of C. gattii to pyrifenox was associated with the expression of efflux pump genes, particularly AFR1 and AFR2, since mutant cells lacking expression of these genes became sensitive to pyrifenox. Analysis of the cryptococcal capsule by India ink counterstaining, immunofluorescence, and scanning electron microscopy showed that pyrifenox affected capsular dimensions in both species. However, GXM fibers were shorter and uniformly distributed in C. neoformans, whereas in C. gattii the number of fibers was reduced. Pyrifenox-treated C. gattii developed unusually long chains of undivided cells. The secretion of GXM was markedly reduced in both species after treatment with pyrifenox. Altogether, the results indicated that pyrifenox differently affects C. neoformans and C. gattii. In addition, it highlights a potential role for pyrifenox as an inhibitor of GXM export in experimental models involving pathogenic cryptococci.<\/jats:p>","DOI":"10.1093\/mmy\/myz132","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T20:10:48Z","timestamp":1576872648000},"page":"928-937","source":"Crossref","is-referenced-by-count":5,"title":["Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii"],"prefix":"10.1093","volume":"58","author":[{"given":"Vanessa K A","family":"Silva","sequence":"first","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Biologia Parasit\u00e1ria, Instituto Oswaldo Cruz (IOC), Funda\u00e7\u00e3o Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5364-1838","authenticated-orcid":false,"given":"Robin C","family":"May","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Infection and School of Biosciences, University of Birmingham, Edgbaston, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-3439","authenticated-orcid":false,"given":"Marcio L","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Instituto Carlos Chagas (ICC), Funda\u00e7\u00e3o Oswaldo Cruz (FIOCRUZ), Curitiba, Brazil"},{"name":"Instituto de Microbiologia Paulo de G\u00f3es, Universidade Federal do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"2020101609550970500_bib1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature10947","article-title":"Emerging fungal threats to animal, plant and ecosystem health","volume":"484","author":"Fisher","year":"2012","journal-title":"Nature"},{"key":"2020101609550970500_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fmicb.2019.00214","article-title":"The still underestimated problem of fungal diseases worldwide","volume":"10","author":"Almeida","year":"2019","journal-title":"Front Microbiol"},{"key":"2020101609550970500_bib3","first-page":"1","author":"Denning"},{"key":"2020101609550970500_bib4","first-page":"57","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel, Switzerland)"},{"key":"2020101609550970500_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","article-title":"Cryptococcus: from environmental saprophyte to global pathogen","volume":"14","author":"May","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"2020101609550970500_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/0074-02760180111","article-title":"Neglected disease, neglected populations: the fight against cryptococcus and cryptococcosis","volume":"113","author":"Rodrigues","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2020101609550970500_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/CMR.00001-12","article-title":"The Cryptococcus neoformans capsule: a sword and a shield","volume":"25","author":"Meara","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"2020101609550970500_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.fbr.2017.09.002","article-title":"Warfare and defense: the host response to Cryptococcus infection","volume":"32","author":"Dutra","year":"2018","journal-title":"Fungal Biol Rev"},{"key":"2020101609550970500_bib9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1590\/0001-3765201520140704","article-title":"Fungal colonization of the brain: anatomopathological aspects of neurological cryptococcosis","volume":"87","author":"Colombo","year":"2015","journal-title":"An Acad Bras Cienc"},{"key":"2020101609550970500_bib10","doi-asserted-by":"crossref","first-page":"e00662","DOI":"10.1128\/IAI.00662-17","article-title":"Regulated release of cryptococcal polysaccharide drives virulence and suppresses immune cell infiltration into the central nervous system","volume":"86","author":"Denham","year":"2018","journal-title":"Infect Immun"},{"key":"2020101609550970500_bib11","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/jac\/dkw325","article-title":"Global access to antifungal therapy and its variable cost","volume":"71","author":"Kneale","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2020101609550970500_bib12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev-micro-030117-020345","article-title":"Molecular evolution of antifungal drug resistance","volume":"71","author":"Robbins","year":"2017","journal-title":"Annu Rev Microbiol"},{"key":"2020101609550970500_bib13","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1128\/EC.00207-09","article-title":"Conservation of the sterol regulatory element-binding protein pathway and its pathobiological importance in cryptococcus neoformans","volume":"8","author":"Chang","year":"2009","journal-title":"Eukaryot Cell"},{"key":"2020101609550970500_bib14","doi-asserted-by":"crossref","first-page":"e01751","DOI":"10.1128\/AAC.01751-17","article-title":"Roles of three Cryptococcus neoformans and Cryptococcus gattii in efflux pump-coding genes in response to drug treatment","volume":"62","author":"Chang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101609550970500_bib15","doi-asserted-by":"crossref","first-page":"e170391","DOI":"10.1590\/0074-02760170391","article-title":"The war on cryptococcosis: a review of the antifungal arsenal","volume":"113","author":"Mourad","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2020101609550970500_bib16","doi-asserted-by":"crossref","first-page":"20150468","DOI":"10.1098\/rstb.2015.0468","article-title":"Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realized","volume":"371","author":"Denning","year":"2016","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"2020101609550970500_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fmicb.2019.00041","article-title":"Drug repurposing for the treatment of bacterial and fungal infections","volume":"10","author":"Mir\u00f3-Canturri","year":"2019","journal-title":"Front Microbiol"},{"key":"2020101609550970500_bib18","doi-asserted-by":"crossref","first-page":"e4761","DOI":"10.7717\/peerj.4761","article-title":"Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis","volume":"6","author":"Truong","year":"2018","journal-title":"PeerJ"},{"key":"2020101609550970500_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fmicb.2017.00535","article-title":"The anti-helminthic compound mebendazole has multiple antifungal effects against Cryptococcus neoformans","volume":"8","author":"Joffe","year":"2017","journal-title":"Front Microbiol"},{"key":"2020101609550970500_bib20","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1473-3099(19)30127-6","article-title":"Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial","volume":"19","author":"Rhein","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2020101609550970500_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17460441.2016.1110142","article-title":"Potential of agricultural fungicides for antifungal drug discovery","volume":"11","author":"Jampilek","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"2020101609550970500_bib22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ps.2179","article-title":"Similarities between the discovery and regulation of pharmaceuticals and pesticides: in support of a better understanding of the risks and benefits of each","volume":"67","author":"Swanton","year":"2011","journal-title":"Pest Manag Sci"},{"key":"2020101609550970500_bib23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.drudis.2006.07.002","article-title":"Modern agrochemical research: a missed opportunity for drug discovery?","volume":"11","author":"Delaney","year":"2006","journal-title":"Drug Discov Today"},{"key":"2020101609550970500_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ps.2780220107","article-title":"Effect of the fungicide pyrifenox on sterol biosynthesis in Ustilago maydis","volume":"22","author":"Masner","year":"1988","journal-title":"Pestic Sci"},{"key":"2020101609550970500_bib25","first-page":"213","article-title":"Sensitivity of Uncinula necator populations following DMI-fungicide usage in Austrian vineyards","volume":"52","author":"Steinkellner","year":"2001","journal-title":"Bodenkultur"},{"key":"2020101609550970500_bib26","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1094\/PHYTO.1997.87.12.1272","article-title":"Acquisition of resistance to sterol demethylation inhibitors by populations of Venturia inaequalis","volume":"87","author":"Kunz","year":"1997","journal-title":"Phytopathology"},{"key":"2020101609550970500_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0261-2194(95)00109-3","article-title":"Controlling powdery mildew caused by Sphaerotheca fuliginea in cucumber by foliar sprays of phosphate and potassium salts","volume":"15","author":"Reuveni","year":"1996","journal-title":"Crop Prot"},{"key":"2020101609550970500_bib28","doi-asserted-by":"crossref","first-page":"e180057","DOI":"10.1590\/0074-02760180057","article-title":"Cryptococcal pathogenic mechanisms: a dangerous trip from the environment to the brain","volume":"113","author":"Esher","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2020101609550970500_bib29","first-page":"e00025","article-title":"Dectin-1-targeted antifungal liposomes exhibit enhanced efficacy","volume":"4","author":"Ambati","year":"2019","journal-title":"MSphere"},{"key":"2020101609550970500_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.mimet.2008.05.010","article-title":"Tetrazolium salts for MIC determination in microplates: Why? Which salt to select? How?","volume":"75","author":"Grare","year":"2008","journal-title":"J Microbiol Methods"},{"key":"2020101609550970500_bib31","first-page":"1","volume-title":"EUCAST Antifungal MIC method for yeasts","author":"EUCAST","year":"2015"},{"key":"2020101609550970500_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0022-1759(92)90209-C","article-title":"Monoclonal antibody based ELISAs for cryptococcal polysaccharide","volume":"154","author":"Casadevall","year":"1992","journal-title":"J Immunol Methods"},{"key":"2020101609550970500_bib33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.funbio.2019.06.003","article-title":"Polysaccharide diversity in VNI isolates of Cryptococcus neoformans from Roraima, Northern Brazil","volume":"123","author":"Dal Pupo","year":"2019","journal-title":"Fungal Biol"},{"key":"2020101609550970500_bib34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/EC.00307-07","article-title":"Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan","volume":"7","author":"Rodrigues","year":"2008","journal-title":"Eukaryot Cell"},{"key":"2020101609550970500_bib35","doi-asserted-by":"crossref","first-page":"e00080","DOI":"10.1128\/mSphere.00080-19","article-title":"A novel protocol for the isolation of fungal extracellular vesicles reveals the participation of a putative scramblase in polysaccharide export and capsule construction in Cryptococcus gattii","volume":"4","author":"Reis","year":"2019","journal-title":"MSphere"},{"key":"2020101609550970500_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/myc.12747","article-title":"A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species","volume":"61","author":"Bongomin","year":"2018","journal-title":"Mycoses"},{"key":"2020101609550970500_bib37","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/myc.12801","article-title":"Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections","volume":"61","author":"Borba","year":"2018","journal-title":"Mycoses"},{"key":"2020101609550970500_bib38","doi-asserted-by":"crossref","first-page":"e00647","DOI":"10.1128\/mBio.00647-15","article-title":"Identification of a new class of antifungals targeting the synthesis of fungal sphingolipids","volume":"6","author":"Mor","year":"2015","journal-title":"MBio"},{"key":"2020101609550970500_bib39","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/jac\/dku554","article-title":"Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans","volume":"70","author":"Basso Jr","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020101609550970500_bib40","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/AAC.01777-15","article-title":"Fluconazole susceptibility in Cryptococcus gattii is dependent on the ABC transporter Pdr11","volume":"60","author":"Yang","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101609550970500_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tcsw.2018.05.002","article-title":"Lack of chitin synthase genes impacts capsular architecture and cellular physiology in Cryptococcus neoformans","volume":"2","author":"Rodrigues","year":"2018","journal-title":"Cell Surf"},{"key":"2020101609550970500_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/EC.00318-06","article-title":"Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport","volume":"6","author":"Rodrigues","year":"2007","journal-title":"Eukaryot Cell"},{"key":"2020101609550970500_bib43","doi-asserted-by":"crossref","first-page":"e11113","DOI":"10.1371\/journal.pone.0011113","article-title":"Characterization of yeast extracellular vesicles: Evidence for the participation of different pathways of cellular traffic in vesicle biogenesis","volume":"5","author":"Oliveira","year":"2010","journal-title":"PLoS One"},{"key":"2020101609550970500_bib44","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1091\/mbc.e04-11-0987","article-title":"Specialization of the HOG pathway and its impact on differentiation and virulence of Cryptococcus neoformans","volume":"16","author":"Bahn","year":"2005","journal-title":"Mol Biol Cell"},{"key":"2020101609550970500_bib45","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/mic.0.28571-0","article-title":"Calcineurin, Mpk1 and Hog1 MAPK pathways independently control fludioxonil antifungal sensitivity in Cryptococcus neoformans","volume":"152","author":"Kojima","year":"2006","journal-title":"Microbiology"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/58\/7\/928\/33902467\/myz132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/58\/7\/928\/33902467\/myz132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T05:01:47Z","timestamp":1665291707000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/58\/7\/928\/5698400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,1,8]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myz132","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,1,8]]}}}